Download presentation
Presentation is loading. Please wait.
Published byApril Hoover Modified over 9 years ago
1
U.S. Genetic Testing Markets New Technologies Drive Genetic Testing Acceptance, Spur Market Growth “The genetic cancer testing market is ideal for micro-array/chip technologies. Once a patient has been diagnosed with a particular gene or genetic mutation, this technology has the potential to detect the levels at which the gene is being expressed.” Clinical Diagnostics Analyst Team Frost & Sullivan
2
Detailed insights into recent developments and trends Drivers, restraints, challenges, and strategic recommendations Analyst insights into ‘hot topics’ and emerging applications in the genetic testing market. Market-sizing and competitive analysis Market forecasts and opportunity analyses Quarterly assessments End-user analysis Key Features
3
Coverage: The United States Proven methodology using extensive primary and secondary data as well as research Focused information and strategies that cover business and technology issues Credible data and analyses that highlight industry dynamics Precise strategies to help you create winning business plans What We Offer
4
Current Market Participants Find out how you compare with the competition Assess current and future drivers as well as restraints Determine and exploit new market share opportunities New Entrants Analyze the associated challenges Calculate timescales for strategy implementation Position yourself to capitalize on the unmet needs of the market Investment Community Analyze long-term strategies of companies Determine participants that will outperform the competition Assess the attractiveness of investing in the market Benefits
5
Affymetrix, Inc. Amersham Pharmacia Biotech/Amersham plc Applied Biosystems/Applera ARUP Laboratories AutoGen/ Iwata Co. Baylor College of Medicine BectonDickinison Beckman Coulter, Inc. Bio-Rad Laboratories, Inc. Cambio, Ltd. Cytocell F. Hoffmann-La Roche Ltd. GeneTests Gentra Systems, Inc. Genzyme Corp. Johns Hopkins Hospital Laboratory Corp. of America LI-COR, Inc. Lifecodes Corp. Mayo Medical Laboratories Myriad Genetics, Inc. Promega Corp. Qiagen (USA) Quest Diagnostics, Inc. Unilab Corp. Ventana Medical Systems, Inc. Visible Genetics, Inc. Vysis, Inc. Key Market Participants
6
Call toll free 877 G O F ROST (877.463.7876) Fax toll free 888.690.3329 E-mail myfrost@frost.com Visit www.frost.com For More Information
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.